Sandoz Group AG (SDZNY)

Market Cap	18.23B
Revenue (ttm)	10.11B
Net Income (ttm)	-8.00M
Shares Out	n/a
EPS (ttm)	-0.02
PE Ratio	n/a
Forward PE	n/a
Dividend	0.38 (0.83%)
Ex-Dividend Date	May 3, 2024

Volume	43,900
Open	41.01
Previous Close	41.27
Day's Range	41.01 - 41.80
52-Week Range	27.79 - 46.80
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Mar 5, 2025

About Sandoz Group AG

Sandoz Group AG develops, manufactures, and markets generic pharmaceuticals and biosimilars worldwide. The company covers therapeutic areas, including cardiovascular, central nervous system, oncology, infectious diseases, pain and respiratory, diabetes, immunology, endocrinology, hematology, and ophthalmology, as well as bone disease. It also provides a portfolio of active pharmaceutical ingredients and finished dosage forms. The company was founded in 1886 and is headquartered in Basel, Switzerland.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1886
• Employees: 22,633
• Stock Exchange: OTCMKTS
• Ticker Symbol: SDZNY

Financial Performance

In 2023, Sandoz Group AG's revenue was $9.98 billion, an increase of 7.23% compared to the previous year's $9.31 billion. Earnings were $77.00 million, a decrease of -90.92%.